• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

NANETS 治疗指南：胃和胰腺神经内分泌肿瘤的良好分化型。

NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas.

机构信息

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA 02115, USA.

出版信息

Pancreas. 2010 Aug;39(6):735-52. doi: 10.1097/MPA.0b013e3181ebb168.

DOI:10.1097/MPA.0b013e3181ebb168
PMID:20664472
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3100728/
Abstract

Well-differentiated neuroendocrine tumors (NETs) of the stomach and pancreas represent 2 major subtypes of gastrointestinal NETs. Historically, there has been little consensus on the classification and management of patients with these tumor subtypes. We provide an overview of well-differentiated NETs of the stomach and pancreas and describe consensus guidelines for the treatment of patients with these malignancies.

摘要

胃和胰腺的高分化神经内分泌肿瘤（NET）代表了胃肠道 NET 的 2 种主要亚型。从历史上看，对于这些肿瘤亚型患者的分类和管理尚未达成共识。我们提供了胃和胰腺高分化 NET 的概述，并描述了治疗这些恶性肿瘤患者的共识指南。

相似文献

1
NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas.NANETS 治疗指南：胃和胰腺神经内分泌肿瘤的良好分化型。
Pancreas. 2010 Aug;39(6):735-52. doi: 10.1097/MPA.0b013e3181ebb168.
2
Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms.胃肠胰神经内分泌肿瘤的分类和病理学。
Endocr Relat Cancer. 2011 Oct 17;18 Suppl 1:S1-16. doi: 10.1530/ERC-11-0013. Print 2011 Oct.
3
Management of Gastrointestinal and Pancreatic Neuroendocrine Tumors.胃肠道和胰腺神经内分泌肿瘤的管理
Surg Oncol Clin N Am. 2020 Apr;29(2):xiii-xiv. doi: 10.1016/j.soc.2020.02.001.
4
The Problem of High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms: Well-Differentiated Neuroendocrine Tumors, Neuroendocrine Carcinomas, and Beyond.高级胃肠胰神经内分泌肿瘤的问题：分化良好的神经内分泌肿瘤、神经内分泌癌及其他。
Endocrinol Metab Clin North Am. 2018 Sep;47(3):683-698. doi: 10.1016/j.ecl.2018.05.001. Epub 2018 Jul 11.
5
Neuroendocrine tumours: clinical presentation and management of localized disease.神经内分泌肿瘤：局限性疾病的临床表现与管理
Cancer Treat Rev. 2003 Oct;29(5):363-70. doi: 10.1016/s0305-7372(03)00072-0.
6
Treatment Strategies for Metastatic Neuroendocrine Tumors of the Gastrointestinal Tract.胃肠道转移性神经内分泌肿瘤的治疗策略
Curr Treat Options Oncol. 2017 Mar;18(3):14. doi: 10.1007/s11864-017-0461-5.
7
Neuroendocrine gastroenteropancreatic tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up.神经内分泌胃肠胰腺肿瘤：ESMO关于诊断、治疗及随访的临床建议
Ann Oncol. 2008 May;19 Suppl 2:ii104-5. doi: 10.1093/annonc/mdn117.
8
The diversity and commonalities of gastroenteropancreatic neuroendocrine tumors.胃胰肠神经内分泌肿瘤的多样性和共性。
Langenbecks Arch Surg. 2011 Mar;396(3):273-98. doi: 10.1007/s00423-011-0739-1. Epub 2011 Jan 28.
9
The NANETS consensus guidelines for the diagnosis and management of gastrointestinal neuroendocrine tumors (nets): well-differentiated nets of the distal colon and rectum.《胃肠胰神经内分泌肿瘤（NETs）诊治的 NANETS 共识指南：远端结肠和直肠的神经内分泌瘤》。
Pancreas. 2010 Aug;39(6):767-74. doi: 10.1097/MPA.0b013e3181ec1261.
10
Treatment of Gastroenteropancreatic Neuroendocrine Tumors.胃肠胰神经内分泌肿瘤的治疗
Surg Pathol Clin. 2019 Dec;12(4):1045-1053. doi: 10.1016/j.path.2019.08.011.

引用本文的文献

1
Unmasking the Silent Culprit: Gastric Neuroendocrine Tumor in the Setting of Iron Deficiency Anemia.揭开隐匿的元凶：缺铁性贫血背景下的胃神经内分泌肿瘤
Cureus. 2025 Jun 14;17(6):e86010. doi: 10.7759/cureus.86010. eCollection 2025 Jun.
2
The Evolving Landscape of GEP-NENs in the Era of Precision Oncology: Molecular Insights into Tumor Heterogeneity.精准肿瘤学时代GEP-NENs的演变格局：对肿瘤异质性的分子见解
Cancers (Basel). 2025 Jun 21;17(13):2080. doi: 10.3390/cancers17132080.
3
Zollinger-Ellison Syndrome Unmasked during Hiatal Hernia Evaluation: A Case Report.在食管裂孔疝评估过程中发现的佐林格-埃利森综合征：一例报告
Case Rep Gastroenterol. 2025 Mar 27;19(1):219-224. doi: 10.1159/000544940. eCollection 2025 Jan-Dec.
4
Endoscopic treatment of rectal neuroendocrine tumors: a consecutive analysis of multi-institutional data.直肠神经内分泌肿瘤的内镜治疗：多机构数据的连续分析
Ann Coloproctol. 2025 Jun;41(3):221-231. doi: 10.3393/ac.2024.00927.0132. Epub 2025 Jun 30.
5
Surgical Management of Gastroenteropancreatic Neuroendocrine Tumors.胃肠胰神经内分泌肿瘤的外科治疗
Cancers (Basel). 2025 Jan 23;17(3):377. doi: 10.3390/cancers17030377.
6
Refractory hypercalcemia caused by parathyroid-hormone-related peptide secretion from a metastatic pancreatic neuroendocrine tumor: a case report.转移性胰腺神经内分泌肿瘤分泌甲状旁腺激素相关肽导致的难治性高钙血症：一例报告
J Med Case Rep. 2025 Feb 10;19(1):54. doi: 10.1186/s13256-025-05074-9.
7
The Role of Dopamine in Gastric Cancer-A Systematic Review of the Pathogenesis Phenomena Developments.多巴胺在胃癌中的作用——发病机制、现象及进展的系统评价
Biomedicines. 2024 Dec 7;12(12):2786. doi: 10.3390/biomedicines12122786.
8
The first case of combined pancreatic neuroendocrine tumour and neuroendocrine carcinoma.首例胰腺神经内分泌肿瘤合并神经内分泌癌病例。
J Surg Case Rep. 2024 Dec 2;2024(12):rjae746. doi: 10.1093/jscr/rjae746. eCollection 2024 Dec.
9
NET guidelines for white patients may not fit Asian patients.针对白人患者的NET指南可能不适用于亚洲患者。
Am J Surg. 2025 Feb;240:116116. doi: 10.1016/j.amjsurg.2024.116116. Epub 2024 Dec 1.
10
Circulating Chromogranin A as a Surveillance Biomarker in Patients with Carcinoids-The CASPAR Study.循环嗜铬粒蛋白A作为类癌患者的监测生物标志物——CASPAR研究
Clin Cancer Res. 2024 Dec 16;30(24):5559-5567. doi: 10.1158/1078-0432.CCR-24-1875.

本文引用的文献

1
Therapies for the medical management of persistent hypoglycaemia in two cases of inoperable malignant insulinoma.两例无法手术的恶性胰岛素瘤患者持续性低血糖的医学治疗。
Eur J Endocrinol. 2010 May;162(5):1001-8. doi: 10.1530/EJE-09-1010. Epub 2010 Feb 17.
2
Protocol for the examination of specimens from patients with neuroendocrine tumors (carcinoid tumors) of the stomach.胃神经内分泌肿瘤（类癌肿瘤）患者标本检查方案
Arch Pathol Lab Med. 2010 Feb;134(2):187-91. doi: 10.5858/134.2.187.
3
Protocol for the examination of specimens from patients with neuroendocrine tumors (carcinoid tumors) of the small intestine and ampulla.小肠和壶腹神经内分泌肿瘤（类癌肿瘤）患者标本检查方案
Arch Pathol Lab Med. 2010 Feb;134(2):181-6. doi: 10.5858/134.2.181.
4
Protocol for the examination of specimens from patients with neuroendocrine tumors (carcinoid tumors) of the colon and rectum.结肠和直肠神经内分泌肿瘤（类癌肿瘤）患者标本检查方案
Arch Pathol Lab Med. 2010 Feb;134(2):176-80. doi: 10.5858/134.2.176.
5
Protocol for the examination of specimens from patients with neuroendocrine tumors (carcinoid tumors) of the appendix.阑尾神经内分泌肿瘤（类癌肿瘤）患者标本检查方案
Arch Pathol Lab Med. 2010 Feb;134(2):171-5. doi: 10.5858/134.2.171.
6
Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set.神经内分泌肿瘤的病理学报告：德尔菲共识过程在最小病理数据集开发中的应用。
Am J Surg Pathol. 2010 Mar;34(3):300-13. doi: 10.1097/PAS.0b013e3181ce1447.
7
Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group.奥曲肽长效注射剂（LAR）对转移性中肠神经内分泌肿瘤患者肿瘤生长控制效果的安慰剂对照、双盲、前瞻性、随机研究：PROMID研究组报告
J Clin Oncol. 2009 Oct 1;27(28):4656-63. doi: 10.1200/JCO.2009.22.8510. Epub 2009 Aug 24.
8
Successful control of intractable hypoglycemia using rapamycin in an 86-year-old man with a pancreatic insulin-secreting islet cell tumor and metastases.雷帕霉素成功控制一名86岁患有胰腺胰岛素分泌胰岛细胞瘤并伴有转移的男性患者的顽固性低血糖症。
J Clin Endocrinol Metab. 2009 Sep;94(9):3157-62. doi: 10.1210/jc.2009-0788. Epub 2009 Jun 30.
9
Progress in the treatment of neuroendocrine tumors.神经内分泌肿瘤的治疗进展
Curr Oncol Rep. 2009 May;11(3):193-9. doi: 10.1007/s11912-009-0028-0.
10
Intraoperative ultrasound of the pancreas.胰腺术中超声检查。
Ultrasound Q. 2009 Mar;25(1):39-48; quiz 48. doi: 10.1097/RUQ.0b013e3181901ce4.